Streetbeat News

Analyst Ratings

WIT

Wipro (NYSE:WIT) reported Q1 earnings of $0.06 per share, missing the analyst consensus estimate of $0.07 by 20 percent. This is a 6.67 percent decrease from the same period last year. The company also reported quarterly sales of $2.78 billion, missing the analyst consensus estimate by 0.02 percent, but marking a 2.04 percent increase from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

July 13, 2023 | 10:16 am

LCID

RIVN

TSLA

Gary Black, Managing Director of Future Fund, has suggested that electric vehicle startup Rivian Automotive (NASDAQ:RIVN) could be an attractive acquisition target for an established automaker. Black believes Rivian is undervalued compared to competitors like Lucid Group (NASDAQ:LCID) and Tesla (NASDAQ:TSLA). He suggests adjusting Rivian's enterprise value by deducting its $11 billion net cash from the market cap, resulting in an enterprise value of $15 billion.

Portfolio Pulse from Shanthi Rexaline

July 13, 2023 | 10:10 am

AZEK

Barclays analyst Matthew Bouley maintains an Overweight rating on AZEK Co (NYSE:AZEK) and raises the price target from $33 to $39.

Portfolio Pulse from Benzinga Newsdesk

July 13, 2023 | 10:09 am

TBLT

HC Wainwright & Co. analyst Kevin Dede maintains a 'Buy' rating on ToughBuilt Industries (NASDAQ:TBLT) but has lowered the price target from $6 to $2.

Portfolio Pulse from richadhand@benzinga.com

July 13, 2023 | 10:09 am

OC

Barclays analyst Matthew Bouley maintains an Overweight rating on Owens-Corning (NYSE:OC) and raises the price target from $135 to $161.

Portfolio Pulse from Benzinga Newsdesk

July 13, 2023 | 10:09 am

PCRX

HC Wainwright & Co. analyst Oren Livnat maintains a 'Buy' rating on Pacira BioSciences (NASDAQ:PCRX) but lowers the price target from $71 to $68.

Portfolio Pulse from richadhand@benzinga.com

July 13, 2023 | 10:08 am

MAS

Barclays analyst Matthew Bouley maintains an Overweight rating on Masco (NYSE:MAS) and raises the price target from $64 to $66.

Portfolio Pulse from Benzinga Newsdesk

July 13, 2023 | 10:08 am

DARE

HC Wainwright & Co. analyst Douglas Tsao has reiterated a 'Buy' rating on Dare Bioscience (NASDAQ:DARE) and maintained a $7 price target.

Portfolio Pulse from richadhand@benzinga.com

July 13, 2023 | 10:07 am

LSEA

Barclays analyst Matthew Bouley maintains an Equal-Weight rating on Landsea Homes (NASDAQ:LSEA) and raises the price target from $8 to $9.

Portfolio Pulse from Benzinga Newsdesk

July 13, 2023 | 10:07 am

SRRK

HC Wainwright & Co. analyst Andres Maldonado has reiterated a 'Buy' rating on Scholar Rock Holding (NASDAQ:SRRK) and maintained a $30 price target.

Portfolio Pulse from richadhand@benzinga.com

July 13, 2023 | 10:06 am